Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pia Leon

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
European Journal of Ophthalmology|November 14, 2024
Treatment of <i>Acanthamoeba</i> keratitis with high dose PHMB (0.08%) monotherapy in clinical practice: A case seriesAntonella Franch, Karl Anders Knutsson, Emilio Pedrotti, et al.
Cornea|February 2, 2023
Recurrent Keratoconus: Corneal Transplants for Keratoconus Develop Tomographic Ectatic ChangesMaria Miura, Pia Leon, Yoav Nahum, et al.
American Journal of Ophthalmology Case Reports|May 22, 2020
Shotgun sequencing to determine corneal infectionMohit Parekh, Vito Romano, Antonella Franch, et al.
Indian Journal of Ophthalmology|December 16, 2020
Biobanking corneal tissues for emergency procedures during COVID-19 eraMohit Parekh, Stefano Ferrari, Alessandro Ruzza, et al.
Cornea|March 24, 2023
Preloaded DMEK With Endothelium Outward: A Multicenter Clinical Study Using DMEK Rapid DeviceGabriela Wojcik, Mohit Parekh, Vito Romano, et al.
American Journal of Ophthalmology|March 15, 2022
Factors Affecting the Success Rate of Preloaded Descemet Membrane Endothelial Keratoplasty With Endothelium-Inward Technique: A Multicenter Clinical StudyMohit Parekh, Emilio Pedrotti, Pietro Viola, et al.
American Journal of Ophthalmology|October 9, 2021
Gender Matching Did Not Affect 2-year Rejection or Failure Rates Following DSAEK for Fuchs Endothelial Corneal DystrophyVito Romano, Mohit Parekh, Gianni Virgili, et al.
Ophthalmology|October 6, 2023
The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial: PHMB 0.08% (Polihexanide) and Placebo versus PHMB 0.02% and Propamidine 0.1John K G Dart, Vincenzo Papa, Paolo Rama, et al.
The Ocular Surface|April 9, 2025
Acanthamoeba keratitis treatment outcomes compared for drug delivery by protocol versus physician's individualised treatmentJohn K G Dart, Vincenzo Papa, Paolo Rama, et al.
Ophthalmology and Therapy|May 15, 2026
A Multicenter, Real-World Experience with Polyhexamethylene Biguanide (PHMB) 0.08% Monotherapy for Treating Acanthamoeba Keratitis: A Retrospective Review of 39 CasesKarl Anders Knutsson, Antonio Di Zazzo, Emilio Pedrotti, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
European Journal of Ophthalmology|November 14, 2024
Treatment of <i>Acanthamoeba</i> keratitis with high dose PHMB (0.08%) monotherapy in clinical practice: A case seriesAntonella Franch, Karl Anders Knutsson, Emilio Pedrotti, et al.
Cornea|February 2, 2023
Recurrent Keratoconus: Corneal Transplants for Keratoconus Develop Tomographic Ectatic ChangesMaria Miura, Pia Leon, Yoav Nahum, et al.
American Journal of Ophthalmology Case Reports|May 22, 2020
Shotgun sequencing to determine corneal infectionMohit Parekh, Vito Romano, Antonella Franch, et al.
Indian Journal of Ophthalmology|December 16, 2020
Biobanking corneal tissues for emergency procedures during COVID-19 eraMohit Parekh, Stefano Ferrari, Alessandro Ruzza, et al.
Cornea|March 24, 2023
Preloaded DMEK With Endothelium Outward: A Multicenter Clinical Study Using DMEK Rapid DeviceGabriela Wojcik, Mohit Parekh, Vito Romano, et al.
American Journal of Ophthalmology|March 15, 2022
Factors Affecting the Success Rate of Preloaded Descemet Membrane Endothelial Keratoplasty With Endothelium-Inward Technique: A Multicenter Clinical StudyMohit Parekh, Emilio Pedrotti, Pietro Viola, et al.
American Journal of Ophthalmology|October 9, 2021
Gender Matching Did Not Affect 2-year Rejection or Failure Rates Following DSAEK for Fuchs Endothelial Corneal DystrophyVito Romano, Mohit Parekh, Gianni Virgili, et al.
Ophthalmology|October 6, 2023
The Orphan Drug for Acanthamoeba Keratitis (ODAK) Trial: PHMB 0.08% (Polihexanide) and Placebo versus PHMB 0.02% and Propamidine 0.1John K G Dart, Vincenzo Papa, Paolo Rama, et al.
The Ocular Surface|April 9, 2025
Acanthamoeba keratitis treatment outcomes compared for drug delivery by protocol versus physician's individualised treatmentJohn K G Dart, Vincenzo Papa, Paolo Rama, et al.
Ophthalmology and Therapy|May 15, 2026
A Multicenter, Real-World Experience with Polyhexamethylene Biguanide (PHMB) 0.08% Monotherapy for Treating Acanthamoeba Keratitis: A Retrospective Review of 39 CasesKarl Anders Knutsson, Antonio Di Zazzo, Emilio Pedrotti, et al.
Pageof 4